What is PTC Therapeutics's net investment in lease?

PTC Therapeutics (PTCT) reported net investment in lease of $76.69M in Q1 2026.

How has PTC Therapeutics's net investment in lease changed year-over-year?

PTC Therapeutics's net investment in lease increased by 33.8% year-over-year, from $57.32M to $76.69M.

What is the long-term trend for PTC Therapeutics's net investment in lease?

Over 5 years (2020 to 2025), PTC Therapeutics's net investment in lease has grown at a -1.1% compound annual growth rate (CAGR), from $84.41M to $80.05M.

PTC Therapeutics PTCT Net Investment in Lease

Net Investment in Lease at other companies

ALN

Alnylam PharmaceuticalsALNY

——

BridgeBio PharmaBBIO

——

Arrowhead ResearchARWR

——

BiogenBIIB

——

Protagonist TherapeuticsPTGX

——

Mirum Pharmaceuticals, Inc.MIRM

——

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

CapEx$1.2M-30.6%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's net investment in lease?: PTC Therapeutics (PTCT) reported net investment in lease of $76.69M in Q1 2026.
How has PTC Therapeutics's net investment in lease changed year-over-year?: PTC Therapeutics's net investment in lease increased by 33.8% year-over-year, from $57.32M to $76.69M.
What is the long-term trend for PTC Therapeutics's net investment in lease?: Over 5 years (2020 to 2025), PTC Therapeutics's net investment in lease has grown at a -1.1% compound annual growth rate (CAGR), from $84.41M to $80.05M.